Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)

ClinicalTrials.gov ID: NCT02611817

Public ClinicalTrials.gov record NCT02611817. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 1:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Subjects With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the effect of vedolizumab subcutaneous (vedolizumab SC) as maintenance treatment in participants with moderately to severely active CD who achieved clinical response following administration of vedolizumab intravenous (vedolizumab IV) induction therapy.

Study identification

NCT ID
NCT02611817
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
644 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 4, 2016 (Actual)
Primary completion
May 6, 2019 (Actual)
Completion
Aug 6, 2019 (Actual)
Last update posted
May 25, 2022

2016 – 2019

United States locations

U.S. sites
30
U.S. states
20
U.S. cities
30
Facility City State ZIP Site status
Arizona Arthritis & Rheumatology Research, PLLC Phoenix Arizona 45806 —
Medical Research Center of Connecticut, LLC Hamden Connecticut 11021 —
Middlesex Gastroenterology Associates Middletown Connecticut — —
Nature Coast Clinical Research, LLC Inverness Florida 55905 —
L & L Research Choices, Inc. Miami Florida — —
Gastroenterology Group of Naples Naples Florida 30342 —
Shafran Gastroenterology Center Winter Park Florida 70809 —
Atlanta Gastroenterology Associates Atlanta Georgia 33176 —
Gastroenterology Associates of Central Georgia Macon Georgia 53226 —
Atlanta Gastroenterology Specialists, PC Suwanee Georgia 48047 —
Grand Teton Research Group, PLL Idaho Falls Idaho — —
Rush University Medical Center Chicago Illinois 33028 —
Carle Foundation Hospital Urbana Illinois 74104 —
Cotton-O'Neil Clinical Research Center, Digestive Health Topeka Kansas 06518 —
Tri-State Gastroenterology Associates Crestview Hills Kentucky 06457 —
Gastroenterology Associates, LLC Baton Rouge Louisiana 85307 —
Louisiana Research Center, LLC Shreveport Louisiana 32789 —
Metropolitan Gastroenterology Group, PC, Chevy Chase Clinical Research Chevy Chase Maryland — —
Clinical Research Institute of Michigan, LLC Chesterfield Michigan 49519 —
Gastroenterology Associates of Western Michigan, P.L.C. Wyoming Michigan 34102 —
Mayo Clinic - Rochester Rochester Minnesota 30024 —
Ehrhardt Clinical Research, LLC Belton Missouri 60612 —
Long Island Clinical Research Associates Great Neck New York 71105 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 41017 —
Gastro-Enterology Research of Lima Lima Ohio 39581 —
Options Health Research Tulsa Oklahoma 83404 —
Gastroenterology Center of the MidSouth PC Germantown Tennessee 78212 —
Vanderbilt University Medical Center Nashville Tennessee 61801 —
San Antonio Gastroenterology San Antonio Texas — —
Allegiance Research Specialists, LLC Milwaukee Wisconsin 64012 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 164 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02611817, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 25, 2022 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02611817 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →